Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.

Alyssa Marie Schlenz

TitleAssociate Professor
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-PEDS

    Collapse Research 
    Collapse research activities and funding
    F31HL108582     (SCHLENZ, ALYSSA MARIE)Aug 21, 2012 - Aug 20, 2013
    NIH
    A Translational Approach to Heterogeneity of Pain in Pediatric Sickle Cell Anemia
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Karlson CW, Barajas KG, Seals SR, Britt AB, Schlenz AM, Jackson EA, Davis DB, Morris MC, Valrie CR. Longitudinal Predictors of Pain in Pediatric Sickle Cell Disease. J Pediatr Psychol. 2023 07 05; 48(6):553-561. PMID: 37043758.
      View in: PubMed
    2. Fraley CE, Neiman JS, Feddersen CR, James C, Jones TG, Mikkelsen M, Nuss R, Schlenz AM, Winters AC, Green AL, Compas BE. Identifying patterns of neurocognitive dysfunction through direct comparison of children with leukemia, central nervous system tumors, and sickle cell disease. Pediatr Blood Cancer. 2023 06; 70(6):e30299. PMID: 37036272.
      View in: PubMed
    3. Phillips S, Schlenz AM, D'Alton S, Johnson M, Kanter J. Patient and Family Opioid Decision-Making for Pain Management in Sickle Cell Disease: A Qualitative Study. J Pain. 2023 Jul; 24(7):1240-1250. PMID: 36863679.
      View in: PubMed
    4. Schlenz AM, Thomas SJ, Gloston G, Lebensburger J, Maxwell SL, Kanter J. Sleep quality and pain in adolescents and young adults with sickle cell disease. J Clin Sleep Med. 2022 12 01; 18(12):2845-2853. PMID: 35975556.
      View in: PubMed
    5. Schlenz AM, Phillips S, Mueller M, Kanter J. Practice Patterns for Addressing Developmental-Behavioral Concerns in Sickle Cell Specialty Care. Clin Pract Pediatr Psychol. 2023 Sep; 11(3):280-290. PMID: 37876414.
      View in: PubMed
    6. Schlenz A, Schatz J. Implementation of Two Developmental Screening Programs in Sickle Cell Disease Specialty Care. Clin Pract Pediatr Psychol. 2023 Jun; 11(2):157-167. PMID: 37456989.
      View in: PubMed
    7. Schlenz AM, Phillips SM, Mueller M, Melvin CL, Adams RJ, Kanter J. Barriers and Facilitators to Chronic Red Cell Transfusion Therapy in Pediatric Sickle Cell Anemia. J Pediatr Hematol Oncol Nurs. 2022 Jul-Aug; 39(4):209-220. PMID: 35791853.
      View in: PubMed
    8. Noisette ML, Phillips S, Schlenz AM, Mueller M, Kanter J. Changes in Care Delivery for Children With Sickle Cell Anemia During the COVID-19 Pandemic. J Pediatr Hematol Oncol. 2021 11 01; 43(8):e1231-e1234. PMID: 33235147.
      View in: PubMed
    9. Kanter J, Phillips S, Schlenz AM, Mueller M, Dooley M, Sirline L, Nickel R, Brown RC, Hilliard L, Melvin CL, Adams RJ. Transcranial Doppler Screening in a Current Cohort of Children With Sickle Cell Anemia: Results From the DISPLACE Study. J Pediatr Hematol Oncol. 2021 11 01; 43(8):e1062-e1068. PMID: 33625093.
      View in: PubMed
    10. Phillips SM, Schlenz AM, Mueller M, Melvin CL, Adams RJ, Kanter J. Identified barriers and facilitators to stroke risk screening in children with sickle cell anemia: results from the DISPLACE consortium. Implement Sci Commun. 2021 Aug 10; 2(1):87. PMID: 34376249.
      View in: PubMed
    11. Phillips S, Schlenz AM, Mueller M, Melvin C, Adams RJ, Kanter J. Practice patterns for neuroimaging and transfusion therapy for management of neurologic complications in sickle cell anemia: DISPLACE consortium. Pediatr Blood Cancer. 2020 11; 67(11):e28569. PMID: 32894002.
      View in: PubMed
    12. Schlenz AM, Phillips S, Mueller M, Melvin C, Adams RJ, Kanter J. Practice patterns for stroke prevention using transcranial Doppler in sickle cell anemia: DISPLACE Consortium. Pediatr Blood Cancer. 2020 04; 67(4):e28172. PMID: 31925913.
      View in: PubMed
    13. Maxwell SL, Schlenz AM, Kanter J. Health-related Quality of Life in Children With Sickle Cell Disease Undergoing Chronic Red Cell Transfusion Therapy. J Pediatr Hematol Oncol. 2019 05; 41(4):307-312. PMID: 31026251.
      View in: PubMed
    14. Schlenz AM, Hayes J, Mueller M, Phillips S, Adams RJ, Kanter J. Incomplete implementation of guideline-based stroke prevention therapy in sickle cell disease. Am J Hematol. 2018 09; 93(9):E222-E224. PMID: 29905391.
      View in: PubMed
    15. Schatz J, Schlenz AM, Smith KE, Roberts CW. Predictive validity of developmental screening in young children with sickle cell disease: a longitudinal follow-up study. Dev Med Child Neurol. 2018 05; 60(5):520-526. PMID: 29488622.
      View in: PubMed
    16. Schatz J, Schlenz A, Reinman L, Smith K, Roberts CW. Developmental Screening in Pediatric Sickle Cell Disease: Disease-Related Risk and Screening Outcomes in 4 Year Olds. J Dev Behav Pediatr. 2017 Oct; 38(8):654-662. PMID: 28816916.
      View in: PubMed
    17. Schlenz AM, Schatz J, Roberts CW. Examining Biopsychosocial Factors in Relation to Multiple Pain Features in Pediatric Sickle Cell Disease. J Pediatr Psychol. 2016 Sep; 41(8):930-40. PMID: 26869665.
      View in: PubMed
    18. Schlenz AM, Boan AD, Lackland DT, Adams RJ, Kanter J. Needs Assessment for Patients with Sickle Cell Disease in South Carolina, 2012. Public Health Rep. 2016 Jan-Feb; 131(1):108-16. PMID: 26843676.
      View in: PubMed
    19. Schlenz AM, Carpenter LA, Bradley C, Charles J, Boan A. Age Differences in Emergency Department Visits and Inpatient Hospitalizations in Preadolescent and Adolescent Youth with Autism Spectrum Disorders. J Autism Dev Disord. 2015 Aug; 45(8):2382-91. PMID: 25739694.
      View in: PubMed
    20. Schatz J, Schlenz AM, McClellan CB, Puffer ES, Hardy S, Pfeiffer M, Roberts CW. Changes in coping, pain, and activity after cognitive-behavioral training: a randomized clinical trial for pediatric sickle cell disease using smartphones. Clin J Pain. 2015 Jun; 31(6):536-47. PMID: 25503599.
      View in: PubMed
    21. Smith TP, Schlenz AM, Schatz JC, Maitra R, Sweitzer SM. Modulation of pain in pediatric sickle cell disease: understanding the balance between endothelin mediated vasoconstriction and apelin mediated vasodilation. Blood Cells Mol Dis. 2015 Feb; 54(2):155-9. PMID: 25486928.
      View in: PubMed
    22. Schlenz AM, McClellan CB, Mark TR, McKelvy AD, Puffer E, Roberts CW, Sweitzer SM, Schatz JC. Sensitization to acute procedural pain in pediatric sickle cell disease: modulation by painful vaso-occlusive episodes, age, and endothelin-1. J Pain. 2012 Jul; 13(7):656-65. PMID: 22633685.
      View in: PubMed
    23. Schlenz AM, Schatz J, McClellan CB, Roberts CW. Responsiveness of the PedsQL to pain-related changes in health-related quality of life in pediatric sickle cell disease. J Pediatr Psychol. 2012 Aug; 37(7):798-807. PMID: 22467881.
      View in: PubMed
    24. Schlenz AM, Schatz J, McClellan CB, Sweitzer SM, Roberts CW. Information-seeking coping behaviors during painful procedures in African-American children with sickle cell disease. Pain Manag Nurs. 2013 Sep; 14(3):e54-8. PMID: 23972871.
      View in: PubMed
    Schlenz's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (93) concept(s)
    _
    Co-Authors Expand Description
    See all (5) people
    _
    Similar People Expand Description
    See all (60) people
    _
    Same Department Expand Description
    Search Department

    Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)